Valuation: Medios AG

Market Cap 248M 278M 229M 208M 389M 26.37B 395M 2.76B 1.09B 13.81B 1.04B 1.02B 43.52B P/E 2026 *
12x
P/E 2027 * 8.43x
Enterprise Value 344M 385M 318M 288M 540M 36.58B 548M 3.83B 1.51B 19.15B 1.45B 1.42B 60.37B EV / Sales 2026 *
0.16x
EV / Sales 2027 * 0.14x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day-0.78%
1 week-2.50%
Current month-9.32%
1 month+1.20%
3 months-19.30%
6 months-23.68%
Current year-30.11%
1 week 10.1
Extreme 10.1
10.52
1 month 10.1
Extreme 10.1
11.52
Current year 9.98
Extreme 9.98
17.44
1 year 9.98
Extreme 9.98
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 2026-01-31
Director of Finance/CFO 54 2026-04-14
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 2014-11-06
Director/Board Member 65 2016-09-13
Director/Board Member 57 2021-06-09
Date Insider Type Main position Quantity % Market Cap. Importance
8/12/26 Buy

Chief Financial Officer

3,500 0.0137%
2/4/26 Sell

Chief Executive Officer

13,638 0.0535%
1/22/26 Buy

Executive/Senior Manager

4,000 0.0157%
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%-2.50%-20.06%-28.63% 278M
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -1.06%+1.70%+31.21%+60.94% 400.46B
Weighted average by Cap. -1.35%+2.66%+40.99%+82.12%

Financials

2026 *2027 *
Net sales 2.17B 2.43B 2B 1.82B 3.4B 230B 3.45B 24.11B 9.54B 121B 9.11B 8.92B 380B 2.25B 2.52B 2.08B 1.88B 3.52B 239B 3.58B 24.99B 9.88B 125B 9.44B 9.24B 394B
Net income 20.76M 23.26M 19.18M 17.39M 32.57M 2.21B 33.05M 231M 91.35M 1.16B 87.26M 85.41M 3.64B 29.51M 33.05M 27.26M 24.72M 46.29M 3.14B 46.97M 328M 130M 1.64B 124M 121M 5.18B
Net Debt 96M 108M 88.67M 80.41M 151M 10.21B 153M 1.07B 422M 5.34B 403M 395M 16.85B 56.62M 63.42M 52.3M 47.42M 88.82M 6.02B 90.12M 630M 249M 3.15B 238M 233M 9.94B
Projected Income Statement - Annual - Medios AG
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
989
Date Price Change Volume
26-10-23 €10.12 -0.78% 8,920
26-10-22 €10.20 -1.92% 24,384
26-10-21 €10.40 -0.38% 3,554
26-10-20 €10.44 +2.35% 18,322
26-10-19 €10.20 -1.73% 14,977
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Medios AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.12EUR
Average target price
20.25EUR
Spread / Average Target
+100.10%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Medios AG
  1. Stock Market
  2. Stocks
  3. ILM1 Stock